Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors

Nayak-Kapoor, Asha; Hao, Zhonglin; Sadek, Ramses; Dobbins, Robin; Marshall, Lisa; Vahanian, Nicholas N.; Jay Ramsey, W.; Kennedy, Eugene; Mautino, Mario R.; Link, Charles J.; Lin, Ray S.; Royer-Joo, Stephanie; Liang, Xiaorong; Salphati, Laurent; Morrissey, Kari M.; Mahrus, Sami; McCall, Bruce; Pirzkall, Andrea; Munn, David H.; Janik, John E.; Khleif, Samir N.

期刊名称Journal for ImmunoTherapy of Cancer
作者Nayak-Kapoor, Asha; Hao, Zhonglin; Sadek, Ramses; Dobbins, Robin; Marshall, Lisa; Vahanian, Nicholas N.; Jay Ramsey, W.; Kennedy, Eugene; Mautino, Mario R.; Link, Charles J.; Lin, Ray S.; Royer-Joo, Stephanie; Liang, Xiaorong; Salphati, Laurent; Morrissey, Kari M.; Mahrus, Sami; McCall, Bruce; Pirzkall, Andrea; Munn, David H.; Janik, John E.; Khleif, Samir N.
卷第6卷
期第1期
电子ISSN2051-1426
文件大小1139.08KB
发表时间2018-12
DOI10.1186/s40425-018-0351-9

发现好书期刊，享受阅读乐趣

Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors